Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.

McPhillips F, Mullen P, Monia BP, Ritchie AA, Dorr A, Smyth JF and Langdon SP

Research output: Contribution to journalArticlepeer-review

Abstract

c-Raf is an essential component of the extracellular related kinase (ERK) signal transduction pathway. Immunohistochemical staining indicated that c-Raf was present in 49/53 ovarian adenocarcinomas investigated and high c-Raf expression correlated significantly with poor survival (P = 0.002). c-Raf protein was detected in 15 ovarian cancer cell lines. Antisense oligodeoxynucleotides (ODNs) (ISIS 5132 and ISIS 13650) reduced c-Raf protein levels and inhibited cell proliferation in vitro. Selectivity was demonstrated by the lack of effect of ISIS 5132 on A-Raf or ERK, while a random ODN produced only minor effects on growth and did not influence c-Raf expression. ISIS 5132 produced enhanced apoptosis and cells accumulated in S and G2/M phases of the cell cycle. In vivo, ISIS 5132 inhibited growth of the s.c. SKOV-3 xenograft while a mismatch ODN had no effect. These data indicate that high levels of c-Raf expression may be important in ovarian cancer and use of antisense ODNs targeted to c-Raf could provide a strategy for the treatment of this disease.
Original languageEnglish
Pages (from-to)1753-1758
Number of pages6
JournalBritish Journal of Cancer
Volume85
DOIs
Publication statusPublished - 2001

Fingerprint

Dive into the research topics of 'Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.'. Together they form a unique fingerprint.

Cite this